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Mitochondrialdysfunctionoftenleadstocelldeathanddisease.Wecannowdrawcorrelationsbetweenthedysfunctionofoneof
the most important mitochondrial enzymes, NADH:ubiquinone reductase or complex I, and its structural organization thanks to
the recent advances in the X-ray structure of its bacterial homologs. The new structural information on bacterial complex I
provide essential clues to ﬁnally understand how complex I may work. However, the same information remains difﬁcult to
interpret for many scientists working on mitochondrial complex I from different angles, especially in the ﬁeld of cell death. Here,
we present a novel way of interpreting the bacterial structural information in accessible terms. On the basis of the analogy to
semi-automatic shotguns, we propose a novel functional model that incorporates recent structural information with previous
evidence derived from studies on mitochondrial diseases, as well as functional bioenergetics.
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Mitochondrial complex I is a large enzyme complex of over 40
subunits embedded in the inner mitochondrial membrane that
forms the ﬁrst site of oxidative phosphorylation.
1 It feeds the
ubiquinone (Q) pool with reducing power collected from the
mitochondrial matrix. Complex I dysfunction is the most
common mitochondrial defect leading to cell death and
disease.
1–3 For a long time, the lack of structural information
has prevented a molecular understanding of the pathological
implications of complex I dysfunction and its overall mechan-
ism of action. Recently, however, detailed structural informa-
tionhasbeen reported forthe membrane-embedded region of
complex I of two bacteria, Escherichia coli and Thermus
thermophilus and of the yeast Yarrowia lipolytica.
4,5
Thisnewstructuralinformationhasrevealedanunexpected
architectureofthe bioenergetic machinery ofcomplex I, with a
large physical separation between the Q reduction site and
the membrane-embedded proton-pumping units. Such phy-
sical separation rules out the majority of models previously
proposed for the mechanism of complex I, based on the
assumption of direct coupling between the chemistry of Q
reduction and the vectorial movement of protons across the
membrane. However, recent proposals for complex I function
still incorporate principles of direct coupling of Q redox
chemistry with indirect proton-pumping devices
6,7 that were
introduced a long time ago.
8 Moreover, the mechanisms
proposed so far do not take into account the biochemical
effects of mitochondrial DNA (mtDNA) pathogenic mutations
and the different complex I speciﬁcity for quinone analogs.
Noticeably, the historical success of the elegant Q cycle
scheme, which has proved so valuable in explaining the
mechanism of cytochrome bc1 complex,
9 continues to
inﬂuence the interpretation of complex I function, even in the
face of the recent structural information. This structural
information sets aside complex I from any previously known
system reacting with Q and pumping protons across the
membrane.
The purpose of this article is to produce a creative
framework to render the recent structural information on
bacterial complex I broadly accessible to scientists interested
in mitochondrial complex I and its implications for cell death
and disease. In this endeavor, we have taken a completely
fresh view of how complex I may work, based on the analogy
with the mechanism of semi-automatic shotguns.
Fitting the Mitochondria-Encoded NADH
Dehydrogenase (ND) Proteins in the Bacterial Structure
The vast majority of mitochondrial genomes contain seven
genesthatformthemembranedomainofcomplexI,whichare
labeled ND1 to ND6 plus ND4L
10,11 (Table 1). All these genes
encode very hydrophobic subunits that are co-translationally
inserted into the mitochondrial membrane with multiple
transmembrane stretches (TMS, Table 1). In some green
algae, however, ND3 and ND4L are not present in the
mitochondrial genome but are instead encoded by nuclear
DNA,
12 suggesting that these subunits may be imported into
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compared with the other ND subunits (Table 1). Plants also
have an additional mitochondria-encoded subunit, ND7.
13
Except ND7, the ND proteins have homologous counterparts
in bacterial complex I, but their nomenclature differs con-
siderablyinthebacteriaforwhichstructuralinformationisnow
available. In Table 1 we present the correspondence between
the bacterial proteins and the mitochondrial ND subunits, with
the human ones as reference for all organisms.
Structure–function insights in mitochondrial complex I have
been previously obtained from the analysis of mutations in the
ND genes that are associated with human diseases.
Disruptive mutations in ND subunits, mostly affecting the
assembly of complex I, are commonly found as somatic
mutations in oncocytic tumors, but not as germline maternally
inherited mutations associated with human diseases, be-
cause of their lethality.
14,15 Instead, many missense muta-
tions affecting conserved residues in ND subunits are
causative of human diseases, ranging from mono-sympto-
matic pathologies, such as Leber’s hereditary optic neuro-
pathy (LHON), to more severe and multi-systemic clinical
phenotypes, such as mitochondrial encephalomyopathy,
lactic acidosis and stroke-like syndrome (MELAS) and Leigh
syndrome.
11 Thus, different clinical entities are most probably
determined by variable degrees of complex I dysfunction.
11,16
The best-studied pathogenic mutations are those associated
with LHON, which map in the ND1, ND4 and ND6 subunits
(Table 1, see also Bridges et al.
17). They have been modeled
to lie in conserved hydrophilic loops protruding at the matrix
side of the mitochondrial membrane, in the ND1 and ND4
subunits, and in a highly conserved TMS in the ND6
subunit.
16–21
Because the equivalent loops of the bacterial homologs of
ND proteins are not yet resolved in the crystal structures,
4,5
it is hard to precisely locate these and other pathological
mutations in the reported structure of bacterial complex I.
However, the combination of modeling studies with current
structural information
4 suggests the presence of hotspots in
complexIstructurethatmaycontainmostofthesepathogenic
mutations.
16,18 A major hotspotin the ND1subunit wouldlie at
the interface between the hydrophilic domain and the
membrane domain of complex I, encompassing part of the
large Q binding pocket and the structural elements that can
transmit redox-driven conformational changes to the proton-
pumping subunits.
4 Moreover, the great majority of the
pathogenic mutations that affect the ND6 subunit lie within
thesecondTMSoftheprotein,
17,19,21suggestingacriticalrole
of this region in complex I function.
Primary and provisionally pathogenic mutations in the
overlappingspectrumofLHON/MELAS/Leighsyndromehave
been found also in the ND5 and ND3 subunits. Conversely,
the ND2 and ND4L subunits harbor only reported, not
conﬁrmed mutations (for the complete list of mtDNA muta-
tions, see the MITOMAP repository
22). Table 1 shows the
number of conﬁrmed and reported mutations for each ND
subunit, as well as the pathogenic potential of the amino acid
substitutions associated with reported mutations as assessed
by the on-line tool PolyPhen-2, which predicts the possible
impact of amino acid substitutions on the structure and
function of human proteins.
23 ND1, ND4, ND5 and ND6 are
most affected by pathogenic mutations (Table 1), suggesting
thatthesesubunitsformthefunctionalcoreinthebioenergetic
machinery mitochondrial complex I (Figure 1). ND3 and ND2
may also have a role in this machinery, because ND3 harbors
conﬁrmed pathogenic mutations and ND2 some potentially
pathogenic mutations (Table 1). However, we note that ND2
has the most divergent structure from its bacterial counter-
parts among all mitochondrial ND proteins.
17,25,28 Conse-
quently, ND2 is less conserved than the ND4 and ND5
proteins,
25,28 despite sharing a similar helical core related to
sodium/proton antiporters.
4 Moreover, the ND2 subunit has
been associated with extra-mitochondrial proteins as well.
29
Consideringthisevidence,weproposeanancillaryroleforthe
ND2 subunit, even if current information cannot exclude its
possible involvement in proton pumping.
24
Pathogenic LHON mutations have been shown to alter the
reaction with either the Q substrate or the quinol product of
complex I and decrease its binding to Q-antagonist inhibitors,
for example, rotenone.
20,21 These functional effects have
been reproduced by site-directed mutagenesis in the equiva-
lent subunits of the bacterial complex.
17,19,30 Consistent with
these ﬁndings, the ND1, ND4 and ND5 subunits have been
shown to bind analogs of various potent inhibitors, from
rotenone to plant acetogenins and synthetic pesticides.
31–34
Table 1 Complex I subunits in the membrane domain and pathogenic mutations
Thermus
thermophilus Escherichia coli
Homo
sapiens TMS
a
Mutations:
reported
b
Mutations:
conﬁrmed
b
Reported mutations
probably damaging
c
NQO8 (Q60019) NuoH (P0AFD4) ND1 (P03886) 8 26 3 13
NQO14 (Q56229) NuoN (P0AFF0) ND2 (P03891) 14 9 0 7
NQO7 (Q56217) NuoA (P0AFC3) ND3 (P03897) 3 1 3 1
NQO13 (Q56228) NuoM (P0AFE8) ND4 (P03905) 14 8 3 4
NQO11 (Q56226) NuoK (P0AFE4) ND4 L (P03901) 3 3 0 3
NQO12 (Q56227) NuoL (P33607) ND5 (P03915) 16 22 3 14
NQO10 (Q56225) NuoJ (P0AFE0) ND6 (P03923) 5 12 5 8
ThetableliststhebacterialsubunitsofthemembranedomainofcomplexIasidetotheirNDcounterpartsinthemitochondria(identiﬁedbyUniProtaccessionnumbers
for each species, in brackets). The mutations in ND genes related to human diseases that have been reported so far are shown. Mutations resulting in amino acid
changes that are probably damaging (last column) have been selected within the reported mutations by using the prediction tool PolyPhen-2.
aTMS, trans membrane
stretches, estimated from crystal structures
4 and also with Phobius: http://phobius.sbc.su.se/index.html.
bAccording to the deﬁnitions and data reported in: http://
mitomap.org/bin/view.pl/MITOMAP/MutationsCodingControl, accessed 5 July 2011.
cNumber of probably or possibly damaging mutations at the protein level, which
have been predicted using PolyPhen-2: http://genetics.bwh.harvard.edu/pph2/index.shtml
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Cell Death and DiseasePotent Complex I Inhibitors May Physically Block its
Conformational Changes
Some subunits belonging to the hydrophilic domain of
complex Ialso contributeto thebinding ofQand its antagonist
inhibitors, in particular the PSST and 49Kd proteins (beef
complex I nomenclature
1).
34,35 Indeed, the available X-ray
structures indicate that complex I contains a large cavity
formed bythe bacterial equivalents ofmitochondrial 49Kd and
PSST subunits, together with ND1 and the ND6-containing
static view mechanical devices
Q
N2
short helix & bolt
long spring helix (HL)
dynamic flow
N2 N2
2. QH2-driven
firing and
compress
1. Q reduction
Q Q
N2 N2
3. Recoil,
relax and
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4. Automatic
proton firing
Figure 1 Complex I may work like a semi-automatic shotgun. The cartoon model previously published by Efremov et al.,
4 with the variation of not having the subunit
equivalent to ND2 as a proton pump,
24 was ﬁrst tilted vertically and then horizontally by 1801 as in Figure 1 of Treberg and Brand.
7 The silhouette, which respects the
dimension of the X-ray structure of Thermus complex I,
4 was then used to outline the modular assembly of the equivalent mitochondrial ND subunits (Table 1). The ND2
subunit is shown behind other subunits for it is postulated to have an ancillary role in proton pumping.
25 The major hotspots for the pathogenic mutations of different ND
subunits are noted by the indicated symbol and arrows (Table 1, see also Bridges et al.
17 for further details on pathogenic ND mutations). Helix HL of subunit ND5
4 is
represented by the long spring that may be analogous to the spring-loaded helices of viral agglutinins and similarly undergo proton-associated conformational changes.
26,27
Here, these changes are considered to be analogous to the re-loading movements of semi-automatic shotguns. The ND1 subunit, perhaps together with adjacent subunits of
the hydrophilic domain (e.g. NQO6
4), provides the short spring that converts the inertia of the recoiling process into automatic forward movement of the ‘bolt’, which is
proposed to be essentially formed by the ND6 subunit as depicted in the top right part of the ﬁgure (in subsequent parts, the image of the short spring and bolt device is not
shown for sake of clarity). (a) Static view, in which The ND3 and ND4L subunits are labeled with lower font size to indicate that they may not form the core of the functional
bioenergetic machinery of mitochondrial complex I, because they are not present in the mitochondrial genomes of some algae
12 and have fewer damaging mutations
(Table 1). Cluster N2 is in light blue to denote its oxidized state. The images on the right illustrate the mechanical devices of complex I that are proposed to be analogous to
those essential in semi-automatic shotguns. (b) Dynamic view in four snapshots (Supplementary Movie 1, for a cartoon showing these and other steps in motion). Step 1 –
Reduction of Q via clusterN2,in turn reduced(dark blue)by NADH via other redoxgroups (only FMN isshown), is accompanied by the uptake of twoprotons from thematrix.
Step2–Theformationoftheubiquinol(QH2)productinducesalargeconformationalchangeinthehydrophilicdomainandtheadjacentND1andND6subunitsleadingtothe
forward movementof the ‘bolt’, represented by the acute angle of the rhombic shape of ND6 along the membrane plane. This ‘ﬁres’ the outwardrelease of two protons by the
ND4and ND5subunits,whilecompressingthe longHL helix. Step 3 – Theubiquinolproduct leavesthe complexallowing thedecompressionof helix HL andthe re-loading of
anothermoleculeofQsubstratefromamembranereservoir(notpictured)intotheQ-reactingcavity.Intherecoilprocess,additionalprotonsaretakenupfromthematrixside,
whilethe springand bolt mechanismis ‘armed’ again. This arming uses the mechanicalenergy provided by the relaxationof thelong HL, whichis connected to the short helix
behindthe‘bolt’byaleverdeviceprimarilyformedbytheND1andND6subunits,inanalogywiththemechanicsofsemi-automaticshotguns.Step4–Theautomaticrelaxation
oftheshorthelixpushestheND6‘bolt’forwardagain,convertingthemechanicalenergydrivenbytheHLhelixrecoilintoan‘automatic’roundofprotonreleasebytheND4and
ND5 pumps, perhaps assisted by the ND2 subunit as well. Conformational type A inhibitors (Table 2) are predicted to block the recoiling of step 3 and 4, in particular
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Cell Death and Diseasebundle in the hydrophobic domain of the complex.
4,5 This
structural evidence appears to be inconsistent with previous
data, suggesting that the ND4 and ND5 subunits of
mitochondrial complex I may bind Q
20 or its antagonist
inhibitors such as fenpyroximate.
33 Clearly, the contribution
of at least four distinct subunits to the large Q-binding pocket
would be sufﬁcient to account for the likely presence of
reaction sites for the quinone substrate, its semiquinone
intermediate and/or the quinol product.
2,6,36,37
However, also the ND2 subunit has been reported to bind a
Q-antagonist, the acetogenin asimicin.
38 Q binding and
reduction at the interface between ND1 and the hydrophilic
domain of the complex may thus produce large conforma-
tional changes that are mechanically transmitted along the
plane of the membrane, progressively involving ND2, ND4
and ND5.
4,39 Fenperoxymate, asimicin, piericidin, rolliniasta-
tins and related potent inhibitors may not only displace Q, but
also prevent the mechanical transmission of these redox-
linked conformational changes, presumably due to their large
energy of binding to the complex. Indeed, they have binding
constants in the nanomolar range.
2
Partial reduction and binding of potent inhibitors change the
conformation of complex I and the mutual relationships of its
subunits.
4,5,37,39–43 Analogous conformational changes occur
in the cytochrome bc1 complex.
9 However, in complex I the
structural alterations induced by the above inhibitors may
produce a profound structural disruption of the connection
between Q reduction and proton pumping.
5 Hence, potent
Q-antagonist inhibitors functionally overlapping piericidin –
previously called type A-inhibitors,
2 now including also
fenperoxymate – may physically act as spanners that block
the mechanical transmission of redox-linked conformational
changes to the proton-pumping subunits.
Table 2 reports experimental evidence that support this
concept. The most potent inhibitors of mitochondrial complex
I, such as the acetogenin rolliniastatin-1 and the antibiotic
piericidin, inhibit more potently the proton-pumping activity
than the redox activity of mitochondrial NADH-Q reductase
(Table 2).
8 These potent complex I inhibitors could then
‘jam’ its protonmotive machinery. Conversely, weak
inhibitors like myxothiazol may not elicit equivalent structural
changes, because they inhibit with comparable potency the
redox and bioenergetic function of NADH:Q reductase
(Table 2).
8
Other Evidence Suggesting a Different Way of
Interpreting Complex I Mechanism
Among the experimental facts that recent models for complex
I can hardly explain is the variability in the bioenergetic
efﬁciency of NADH:Q reductase catalysis. Although the
general consensus assigns a stoichiometry of four protons
per NADH oxidized or ubiquinol produced (without counting
the two scalar protons required for quinol formation
6,35), the
stoichiometry, which can be experimentally measured varies
considerably depending on the Q substrate used. Although
hydrophobic quinones like decyl-Q elicit bioenergetic reac-
tions equivalent to those of endogenous Q-10, hydrophilic Q
analogs such as Q-0 induce little proton pumping in their
rotenone-sensitive reaction with complex I.
44,45 In the Q tail
there appears to be a very narrow chemical threshold for
inducing the shift from the half-efﬁcient to the fully-efﬁcient
capacity of proton pumping.
44,45 These differences cannot be
due to mere partition effects in the membrane or interaction
with redox groups in the hydrophilic domain of the complex,
46
because the measured reactions remained sensitive to
Q-antagonist inhibitors.
2,44,45,47 Direct coupling mechanisms
(e.g., Ohnishi et al.
6; Treberg and Brand
7), as well as the
‘two-stroke’ mechanism proposed by Brandt while this work was
in progress,
48 can hardly explain the narrow chemical threshold
found in the proton-pumping efﬁciency of complex I.
45
The recent structure of Thermus complex I shows a cavity
that can easily accommodate at least one isoprenoid unit in
the hydrophobic tail of Q, even if a Q molecule was not visible
in the X-ray images.
4 This Q-reacting cavity is embedded in a
region that is exposed beyond the limit of the lipid membrane,
protruding at its matrix (negative) side.
5,17 There, bound Q
would be at a sufﬁcient distance from the closest redox group
of the hydrophilic arm, iron–sulfur cluster N2, to allow rapid
electron transfer yielding the semiquinone and quinol pro-
ducts.
4–7
A recently proposed mechanism considers the known pH-
dependence of N2 oxido–reduction as a vehicle for proton
uptake at the matrix side of the membrane, in a way that leads
to full translocation of the same (and at least another) proton
totheoppositesideofthemembrane.
7Thisuptakeofaproton
at the N2-Q junction might compensate for the partial counter-
charge separation due to electron transfer between N2 and
bound Q, leaving a net charge separation of approximately
one-half negative inside, that is, equivalent to that observed
experimentally.
47 However, at the moment it appears totally
conjectural how a proton taken up by N2 in the matrix then
ends up at the opposite side of the membrane, from which
bound Q would be separated by no less than 4nm.
4,5 The
same structural evidence does not support the presence of a
semiquinone-gated proton pump associated with Q reduction
by complex I.
6 Hence, we ﬁnd our similar proposal of
semiquinone-gated pumps
8 to be clearly untenable. Here,
we provide a new way to envisage how complex I works,
which leaves aside any similarity with other Q-reacting
enzymes.
Table 2 Potent inhibitors of complex I may act as conformational blockers
Inhibitor
I50 proton
pumping
(nmol/mg
of protein)
Ratio of I50
proton
pumping
With I50 redox
a Notes
Rolliniastatin-1 0.03 0.68 Type A
Rolliniastatin-2 0.05 0.59 Type A
Piericidin 0.03 0.49 Type A
Rotenone 0.04 1.08 Not A
Myxothiazol 22.00 1.45 Weak
Tightly coupled submitochondrial particles from beef or sheep heart were
prepared and assayed as described earlier,
44,45 with 0.1mM NADH and
saturating concentrations of undecyl-Q, in the presence of complex II and
cytochrome bc1 complex inhibitors. The table shows values of I50 for inhibitors
that are nearly stoichiometric with complex I
8—except for myxothyazol, which
inhibits complex I more weakly than the cytochrome bc1 complex
2.
aAverage of
at least four separate experiments
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Cell Death and DiseaseThe Quinol-Triggered Semi-Automatic Shotgun Model
for Mitochondrial Complex I
Our proposed model ﬂips upside down the structure of
complex I,
4 as recently shown in Treberg and Brand,
7 to
make it resemble a gun (Figure 1). The shape similarity,
although accidental, has suggested us a functional analogy
with the mechanism of shotguns. The mechanism of semi-
automatic shotguns relies on two essential devices (Figure 1,
top right): a long spring that drives the recoil action of the
barrel and a short spring that is located in the back of the ﬁring
chamber and transfers its inertial momentum to the bolt via a
lever system connected to the long spring. Spring-loaded
conformational changes have been previously proposed for
viral agglutinins with membrane fusion capacity, which extend
the length of amphipatic a helices in response to a lower
pH.
26,27 Similar changes have been reported also for
mammalian membrane proteins.
49
The structure of bacterial complex I shows a very long a
helix, helix HL, that runs parallel to the membrane plane
spanning most of the hydrophobic domain, with a central
interruption.
4 A similar long helix is present in the mitochon-
drialcomplexI
5andapparentlyalsoinitsplastidialhomolog.
28
The long helix HL has been proposed to act as a piston or rod
driving the proton-pumping action of the antiporter-like
subunits of complex I.
4,6,48 We consider instead that this HL
helix may store energy in a spring-loaded fashion as viral
agglutinins
26,27 and is therefore analogous to the long spring
exploiting the recoil of semi-automatic shotguns. Expanding
the analogy further, one or more of the tilted helixes observed
at the rear of the Q cavity in the bacterial complex
4 may
function as the short spring transferring inertia to a shotgun
bolt.Thesehelicesbelongtothebacterialsubunitcorrespond-
ing to ND1, the protein most consistently associated with
the binding of Q and its inhibitors in the mitochondrial
complex I.
16,20,31,32,34,37,50 Of note, the elastic capacity of
tilted helices has been already described.
49,51 In mammalian
mitochondria, it is entirely possible that additional subunits of
both the hydrophobic and the hydrophilic domain
1 may
contribute to this proposed spring-loaded mechanism and its
ﬁne regulation.
In a ﬁnal step of the analogy with shotguns, we propose that
the formation of the ubiquinol product acts as a sort of trigger
for ‘ﬁring’ protons outside mitochondria, ﬁrst directly and then
automatically. The free energy associated with the second
electron transferred from the iron–sulfur clusters of the
hydrophilic domain to bound Q
7 would explosively drive the
forward movement of the ‘bolt’, thus ‘ﬁring’ the proton-
pumping activity of the distal membrane subunits. It will also
be partially converted into mechanical energy, via conforma-
tional changes that compress the long HL helix along the
membrane plane. In the subsequent recoil of the HL helix,
protons could be taken up from the matrix side by the de-
protonated pumps, while an additional Q substrate could be
inserted in the reaction pocket, aided by the sliding movement
of membrane elements associated with HL helix recoil.
Notably, the energy released by the mechanical relaxation
ofthesameHLhelixwouldthen‘arm’againthespringandbolt
device via conformational changes transmitted by inter-
connected parts of the ND6 and ND1 subunits (Figure 1b,
step 3). The process would link the sliding movement of the
long helical spring (C-terminal part of helix HL) to an elastic
compression of the short spring, whose relaxation will then
push forward the ‘bolt’ again, leading to an automatic ﬁring of
the protons previously inserted in the pumps. Hence, two
functional proton pumps
8,24,48 would be sufﬁcient to produce
the maximal stoichiometry of proton translocation by complex
I, because they would automatically ﬁre twice with a single
release of the product ubiquinol. Although ND4 and ND5 are
postulated to form the proton pumps in complex I (Figure 1
and Supplementary Movie 1), it is possible that the ND2
subunit providesbackupreinforcement fortheautomaticﬁring
of protons.
Conclusions and Perspectives for the New Shotgun
Model of Complex I
The basic feature of the new shotgun model for complex I
(Figure 1 and Supplementary Movie 1) is that it eliminates the
requirement of semiquinone-linked pumps
6,8 or other devices
ofdirectcoupling,whichdonotseemtobecompatiblewiththe
structural information available for bacterial complex I.
4 Our
model implies that most of the bioenergetic function of
complex I resides in the proton-pumping subunits ND4 and
ND5. These proteins can ﬁre protons outside in two automatic
rounds per every quinol produced, via a mechanism provided
by spring-loaded helical structures intimately inter-locked
within the hydrophobic domain of the complex, dynamically
connecting proximal Q reduction to distal proton pumping
(Figure 1). Additionally, the present model provides a new
explanation for the following pieces of evidence:
(1) The involvement of the distal subunits ND5, ND4 – and
alsotheND2homologofbacteria–inthebindingofpotent
Q antagonist inhibitors such as plant acetogenins,
6,20,33
even if these subunits are far away from the Q-reacting
pocket in the complex.
4 The potent inhibitors may
physically disrupt the long distance connections between
distal proton pumping and proximal Q reduction at
differentpointsofthehydrophobicdomainofthecomplex.
(2) The increased potency of potent type A inhibitors for the
proton-pumping activity of NADH:Q reductase (Table 2),
8
similarly to the action of amiloride-like inhibitors of the
antiporter activity of the complex.
6,32 By disrupting key
conformational changes, these inhibitors also block the
re-loading of the Q substrate into its reaction pocket,
thereby jamming the spring-loaded action of proton
pumping.
(3) The charge separation that occur upstream of the rotenone
site.
8,36 Besides the redox-linked protonation of the N2
cluster,
7 it may derive from the spring-loading of ND4 and
ND5 with matrix-derived protons during recoiling.
47
(4) The Q-dependent variability in the bioenergetic efﬁciency
of complex I.
44,45 Hydrophilic Q analogs would be unable
to enter the membrane sliding process driven by the HL
helix that re-loads the empty Q reacting chamber –
therefore, they can elicit only a single ﬁring of protons by
the complex.
(5) That most of the energy of Q reduction seems to be
released with the second electron forming the quinol
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7,52 Indeed, quinol formation would act as the
trigger for ﬁring protons outside the membrane.
(6) The concentration of pathological mutations in hotspots is
contributed by multiple ND subunits. A central hotspot is
proposed to lie in the intricate part of the complex that
connects Q reduction with distal proton pumping (Fig-
ure 1). Multiple points of attrition are likely to be present in
such a delicate part of the functional mechanism
53 and
pathogenicmutationsinthe NDproteins maystressthese
points, then affecting the whole bioenergetic capacity of
the complex.
Other models proposed to date do not seem to account for all
the above pieces ofevidence. However, this hypothesisis just
a new view of assembling together recent structural informa-
tion for bacterial complex I with previous evidence accumu-
lated for mitochondrial complex I and render it attractive to the
celldeathﬁeld.Clearly,themodelanditspostulates(Figure1)
are open to intellectual and experimental challenges, in the
perspective of improving even further the understanding of
one of the most complex enzymes in nature and its frequent
involvement in disease.
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